Genome scanning of Amazonian Plasmodium falciparum shows subtelomeric instability and clindamycin-resistant parasites

Genome Research

Volumn 20, Issue 11, 2010, Pages 1534-1544

  Dharia, Neekesh V ^a   Plouffe, David ^b   Bopp, Selina E R ^a   González Páez, Gonzalo E ^a   Lucas, Carmen ^c   Salas, Carola ^c   Soberon, Valeria ^c   Bursulaya, Badry ^b   Kochel, Tadeusz J ^c   Bacon, David J ^c   Winzeler, Elizabeth A ^a,b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b GENOMICS INSTITUTE OF THE NOVARTIS RESEARCH FOUNDATION   (United States)

^c Peru   (Peru)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; CLINDAMYCIN; LINCOSAMIDE DERIVATIVE; MEFLOQUINE; MIRINCAMYCIN; PYRIMETHAMINE; QUININE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; APICOPLAST; ARTICLE; CHROMOSOMAL INSTABILITY; COPY NUMBER VARIATION; GENE REPLICATION; GENE SEQUENCE; GENOTYPE; GEOGRAPHIC DISTRIBUTION; IN VITRO STUDY; MEIOSIS; MITOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM FALCIPARUM; POINT MUTATION; PRIORITY JOURNAL; PROTOZOAL GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM; TELOMERE;

ANTIMALARIALS; BASE SEQUENCE; CHROMOSOMAL INSTABILITY; CHROMOSOME MAPPING; CLINDAMYCIN; DNA COPY NUMBER VARIATIONS; DRUG RESISTANCE; FEMALE; GENE FREQUENCY; GENOME, PROTOZOAN; GENOTYPE; HUMANS; INFANT; MALARIA, FALCIPARUM; MALE; MODELS, BIOLOGICAL; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEDIGREE; PERU; PLASMODIUM FALCIPARUM; PREGNANCY; TELOMERE;

PLASMODIUM FALCIPARUM;

EID: 78649245868     PISSN: 10889051     EISSN: 15495469     Source Type: Journal    
DOI: 10.1101/gr.105163.110     Document Type: Article

References (83)

1. Alkhalil A, Pillai AD, Bokhari AA, Vaidya AB, Desai SA. 2009. Complex inheritance of the plasmodial surface anion channel in a Plasmodium falciparum genetic cross. Mol Microbiol 72: 459-469.
2. Anderson TJ, Haubold B, Williams JT, Estrada-Franco JG, Richardson L, Mollinedo R, Bockarie M, Mokili J, Mharakurwa S, French N, et al. 2000. Microsatellite markers reveal a spectrum of population structures in the malaria parasite Plasmodium falciparum. Mol Biol Evol 17: 1467-1482.
3. Aramburu Guarda J, Ramal Asayag C, Witzig R. 1999. Malaria reemergence in the Peruvian Amazon region. Emerg Infect Dis 5: 209-215. (Pubitemid 29200618)
4. Ariey F, Chalvet W, Hommel D, Peneau C, Hulin A, Mercereau-Puijalon O, Duchemin JB, Sarthou JL, Reynes JM, Fandeur T. 1999. Plasmodium falciparum parasites in French Guiana: Limited genetic diversity and high selfing rate. Am J Trop Med Hyg 61: 978-985. (Pubitemid 30084125)
5. Bacon DJ, McCollum AM, Griffing SM, Salas C, Soberon V, Santolalla M, Haley R, Tsukayama P, Lucas C, Escalante AA, et al. 2009. Dynamics of malaria drug resistance patterns in the Amazon basin region following changes in Peruvian national treatment policy for uncomplicated malaria. Antimicrob Agents Chemother 53: 2042-2051.
6. Bell DR, Wilson DW, Martin LB. 2005. False-positive results of a Plasmodium falciparum histidine-rich protein 2-detecting malaria rapid diagnostic test due to high sensitivity in a community with fluctuating low parasite density. Am J Trop Med Hyg 73: 199-203.
7. + exchanger activity and quinine resistance. Mol Biochem Parasitol 153: 48-58.
8. Borrmann S, Issifou S, Esser G, Adegnika AA, Ramharter M, Matsiegui PB, Oyakhirome S, Mawili-Mboumba DP, Missinou MA, Kun JF, et al. 2004. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria. J Infect Dis 190: 1534-1540. (Pubitemid 39411000)
9. Branch O, Casapia WM, Gamboa DV, Hernandez JN, Alava FF, Roncal N, Alvarez E, Perez EJ, Gotuzzo E. 2005. Clustered local transmission and asymptomatic Plasmodium falciparum and Plasmodium vivax malaria infections in a recently emerged, hypoendemic Peruvian Amazon community. Malar J 4: 27. doi: 10.1186/1475-2875-4-27. (Pubitemid 41214251)
10. Burkhardt D, Wiesner J, Stoesser N, Ramharter M, Uhlemann AC, Issifou S, Jomaa H, Krishna S, Kremsner PG, Borrmann S. 2007. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro. Int J Parasitol 37: 777-785.
11. Camps M, Arrizabalaga G, Boothroyd J. 2002. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol Microbiol 43: 1309-1318. (Pubitemid 34304545)
12. Cannone JJ, Subramanian S, Schnare MN, Collett JR, D'Souza LM, Du Y, Feng B, Lin N, Madabusi LV, Muller KM, et al. 2002. The comparative RNA web (CRW) site: An online database of comparative sequence and structure information for ribosomal, intron, and other RNAs. BMC Bioinformatics 3: 2. doi: 10.1186/1471-2105-3-2.
13. Case DA, Darden TA, Cheatham TE III, Simmerling CL, Wang J, Duke RE, Luo R, Merz KM, Pearlman DA, Crowley M, et al. 2006. Amber 9. University of California, San Francisco, CA.
14. Chenet SM, Branch OH, Escalante AA, Lucas CM, Bacon DJ. 2008. Genetic diversity of vaccine candidate antigens in Plasmodium falciparum isolates from the Amazon basin of Peru. Malar J 7: 93. doi: 10.1186/1475-2875-7-93.
15. Chou HH, Holmes MH. 2001. DNA sequence quality trimming and vector removal. Bioinformatics 17: 1093-1104.
16. Conway DJ, Roper C, Oduola AM, Arnot DE, Kremsner PG, Grobusch MP, Curtis CF, Greenwood BM. 1999. High recombination rate in natural populations of Plasmodium falciparum. Proc Natl Acad Sci 96: 4506-4511.
17. Creasey A, Mendis K, Carlton J, Williamson D, Wilson I, Carter R. 1994. Maternal inheritance of extrachromosomal DNA in malaria parasites. Mol Biochem Parasitol 65: 95-98. (Pubitemid 24232819)
18. Dahl EL, Rosenthal PJ. 2008. Apicoplast translation, transcription and genome replication: Targets for antimalarial antibiotics. Trends Parasitol 24: 279-284.
19. Dharia NV, Sidhu AB, Cassera MB, Westenberger SJ, Bopp SE, Eastman RT, Plouffe D, Batalov S, Park DJ, Volkman SK, et al. 2009. Use of high-density tiling microarrays to globally identify mutations and elucidate mechanisms of drug resistance in Plasmodium falciparum. Genome Biol 10: R21. doi: 10.1186/gb-2009-10-2-r21.
20. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, et al. 2009. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 361: 455-467.
21. Durand S, Marquino W, Cabezas C, Utz G, Fiestas V, Cairo J, Puray M, Lucas C, Salas C, Gutierrez S, et al. 2007. Unusual pattern of Plasmodium falciparum drug resistance in the northwestern Peruvian Amazon region. Am J Trop Med Hyg 76: 614-618.
22. Eastman RT, Fidock DA. 2009. Artemisinin-based combination therapies: A vital tool in efforts to eliminate malaria. Nat Rev Microbiol 7: 864-874.
23. Eckstein-Ludwig U, Webb RJ, Van Goethem ID, East JM, Lee AG, Kimura M, O'Neill PM, Bray PG, Ward SA, Krishna S. 2003. Artemisinins target the SERCA of Plasmodium falciparum. Nature 424: 957-961. (Pubitemid 37051688)
24. Ferdig MT, Cooper RA, Mu J, Deng B, Joy DA, Su XZ, Wellems TE. 2004. Dissecting the loci of low-level quinine resistance in malaria parasites. Mol Microbiol 52: 985-997. (Pubitemid 38916169)
25. Fidock DA, Nomura T, Talley AK, Cooper RA, Dzekunov SM, Ferdig MT, Ursos LM, Sidhu AB, Naude B, Deitsch KW, et al. 2000. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Mol Cell 6: 861-871.
26. Gamboa D, Ho MF, Bendezu J, Torres K, Chiodini PL, Barnwell JW, Incardona S, Perkins M, Bell D, McCarthy J, et al. 2010. A large proportion of P. falciparum isolates in the Amazon region of Peru lack pfhrp2 and pfhrp3: Implications for malaria rapid diagnostic tests. PLoS ONE 5: e8091. doi: 10.1371/journal.pone.0008091.
27. Gonzales JM, Patel JJ, Ponmee N, Jiang L, Tan A, Maher SP, Wuchty S, Rathod PK, Ferdig MT. 2008. Regulatory hotspots in the malaria parasite genome dictate transcriptional variation. PLoS Biol 6: e238. doi: 10.1371/journal.pbio. 0060238.
28. Greenwood BM, Fidock DA, Kyle DE, Kappe SH, Alonso PL, Collins FH, Duffy PE. 2008. Malaria: Progress, perils, and prospects for eradication. J Clin Invest 118: 1266-1276. (Pubitemid 351500419)
29. Haddad D, Snounou G, Mattei D, Enamorado IG, Figueroa J, Stahl S, Berzins K. 1999. Limited genetic diversity of Plasmodium falciparum in field isolates from Honduras. Am J Trop Med Hyg 60: 30-34. (Pubitemid 29065999)
30. Hall AP, Doberstyn EB, Nanokorn A, Sonkom P. 1975. Falciparum malaria semi-resistant to clindamycin. Br Med J 2: 12-14.
31. Harinasuta T, Suntharasamai P, Viravan C. 1965. Chloroquine-resistant falciparum malaria in Thailand. Lancet 2: 657-660.
32. Harris EH, Burkhart BD, Gillham NW, Boynton JE. 1989. Antibiotic resistance mutations in the chloroplast 16S and 23S rRNA genes of Chlamydomonas reinhardtii: Correlation of genetic and physical maps of the chloroplast genome. Genetics 123: 281-292.
33. Hayton K, Gaur D, Liu A, Takahashi J, Henschen B, Singh S, Lambert L, Furuya T, Bouttenot R, Doll M, et al. 2008. Erythrocyte binding protein PfRH5 polymorphisms determine species-specific pathways of Plasmodium falciparum invasion. Cell Host Microbe 4: 40-51.
34. Held J, Westerman R, Kremsner PG, Mordmuller B. 2010. In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon. Antimicrob Agents Chemother 54: 540-542.
35. Jambou R, Legrand E, Niang M, Khim N, Lim P, Volney B, Ekala MT, Bouchier C, Esterre P, Fandeur T, et al. 2005. Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6. Lancet 366: 1960-1963. (Pubitemid 41713986)
36. Jeffares DC, Pain A, Berry A, Cox AV, Stalker J, Ingle CE, Thomas A, Quail MA, Siebenthall K, Uhlemann AC, et al. 2007. Genome variation and evolution of the malaria parasite Plasmodium falciparum. Nat Genet 39: 120-125.
37. Joy DA, Feng X, Mu J, Furuya T, Chotivanich K, Krettli AU, Ho M, Wang A, White NJ, Suh E, et al. 2003. Early origin and recent expansion of Plasmodium falciparum. Science 300: 318-321. (Pubitemid 36433721)
38. Kidgell C, Volkman SK, Daily J, Borevitz JO, Plouffe D, Zhou Y, Johnson JR, Le Roch K, Sarr O, Ndir O, et al. 2006. A systematic map of genetic variation in Plasmodium falciparum. PLoS Pathog 2: e57. doi: 10.1271/journal.ppat.0020057.
39. Kurtz S, Phillippy A, Delcher AL, Smoot M, Shumway M, Antonescu C, Salzberg SL. 2004. Versatile and open software for comparing large genomes. Genome Biol 5: R12. doi: 10.1185/gb-2004-5-2-r12.
40. Martin SK, Rajasekariah GH, Awinda G, Waitumbi J, Kifude C. 2009. Unified parasite lactate dehydrogenase and histidine-rich protein ELISA for quantification of Plasmodium falciparum. Am J Trop Med Hyg 80: 516-522.
41. Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson A.J. 2009. AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J Comput Chem 30: 2785-2791.
42. Mu J, Myers RA, Jiang H, Liu S, Ricklefs S, Waisberg M, Chotivanich K, Wilairatana P, Krudsood S, White NJ, et al. 2010. Plasmodium falciparum genome-wide scans for positive selection, recombination hot spots and resistance to antimalarial drugs. Nat Genet 42: 268-271.
43. Myers AM, Grant DM, Rabert DK, Harris EH, Boynton JE, Gillham NW. 1982. Mutants of Chlamydomonas reinhardtii with physical alterations in their chloroplast DNA. Plasmid 7: 133-151.
44. Nair S, Miller B, Barends M, Jaidee A, Patel J, Mayxay M, Newton P, Nosten F, Ferdig MT, Anderson TJ. 2008. Adaptive copy number evolution in malaria parasites. PLoS Genet 4: e1000243. doi: 10.1371/journal.pgen.1000243.
45. Neafsey DE, Schaffner SF, Volkman SK, Park D, Montgomery P, Milner DA Jr, Lukens A, Rosen D, Daniels R, Houde N, et al. 2008. Genome-wide SNP genotyping highlights the role of natural selection in Plasmodium falciparum population divergence. Genome Biol 9: R171. doi: 10.1186/gb-2008-0-12-4171.
46. Okamoto N, Spurck TP, Goodman CD, McFadden GI. 2009. Apicoplast and mitochondrion in gametocytogenesis of Plasmodium falciparum. Eukaryot Cell 8: 128-132.
47. Olliaro P, Wells TN. 2009. The global portfolio of new antimalarial medicines under development. Clin Pharmacol Ther 85: 584-595.
48. Pieroni P, Mills CD, Ohrt C, Harrington MA, Kain KC. 1998. Comparison of the ParaSight-F test and the ICT Malaria Pf test with the polymerase chain reaction for the diagnosis of Plasmodium falciparum malaria in travellers. Trans R Soc Trop Med Hyg 92: 166-169. (Pubitemid 28200792)
49. Price RN, Uhlemann AC, Brockman A, McGready R, Ashley E, Phaipun L, Patel R, Laing K, Looareesuwan S, White NJ, et al. 2004. Mefloquine resistance in Plasmodium falciparum and increased pfmdr1 gene copy number. Lancet 364: 438-447. (Pubitemid 39036891)
50. Raj DK, Mu J, Jiang H, Kabat J, Singh S, Sullivan M, Fay MP, McCutchan TF, Su XZ. 2009. Disruption of a Plasmodium falciparum multidrug resistance-associated protein (PfMRP) alters its fitness and transport of antimalarial drugs and glutathione. J Biol Chem 284: 7687-7696.
51. Ramya TN, Mishra S, Karmodiya K, Surolia N, Surolia A. 2007. Inhibitors of nonhousekeeping functions of the apicoplast defy delayed death in Plasmodium falciparum. Antimicrob Agents Chemother 51: 307-316. (Pubitemid 46047720)
52. Rathod PK, McErlean T, Lee PC. 1997. Variations in frequencies of drug resistance in Plasmodium falciparum. Proc Natl Acad Sci 94: 9389-9393.
53. Roberts MC. 2008. Update on macrolide-lincosamide-streptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol Lett 282: 147-159.
54. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. 2004. Intercontinental spread of pyrimethamine-resistant malaria. Science 305: 1124. doi: 10.1126/science.1098876.
55. Rosenberg E, Litus I, Schwarzfuchs N, Sinay R, Schlesinger P, Golenser J, Baumeister S, Lingelbach K, Pollack Y. 2006. pfmdr2 confers heavy metal resistance to Plasmodium falciparum. J Biol Chem 281: 27039-27045. (Pubitemid 44401732)
56. Roshanravan B, Kari E, Gilman RH, Cabrera L, Lee E, Metcalfe J, Calderon M, Lescano AG, Montenegro SH, Calampa C, et al. 2003. Endemic malaria in the Peruvian Amazon region of Iquitos. Am J Trop Med Hyg 69: 45-52.
57. Rottman M, McNamara C, Yeung BKS, Lee MCS, Zou B, Russell B, Seitz P, Plouffe DM, Dharia NV, Tan J, et al. 2010. Spiroindolones, a potent compound class for the treatment of Malaria. Science 329: 1175-1180.
58. Schlunzen F, Zarivach R, Harms J, Bashan A, Tocilj A, Albrecht R, Yonath A, Franceschi F. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413: 814-821.
59. Schmidt LH. 1985. Enhancement of the curative activity of primaquine by concomitant administration of mirincamycin. Antimicrob Agents Chemother 27: 151-157.
60. Sidhu AB, Verdier-Pinard D, Fidock DA. 2002. Chloroquine resistance in Plasmodium falciparum malaria parasites conferred by pfcrt mutations. Science 298: 210-213.
61. Sidhu AB, Valderramos SG, Fidock DA. 2005. pfmdr1 mutations contribute to quinine resistance and enhance mefloquine and artemisinin sensitivity in Plasmodium falciparum. Mol Microbiol 57: 913-926.
62. Sidhu AB, Uhlemann AC, Valderramos SG, Valderramos JC, Krishna S, Fidock DA. 2006. Decreasing pfmdr1 copy number in plasmodium falciparum malaria heightens susceptibility to mefloquine, lumefantrine, halofantrine, quinine, and artemisinin. J Infect Dis 194: 528-535.
63. Sidhu AB, Sun Q, Nkrumah LJ, Dunne MW, Sacchettini JC, Fidock DA. 2007. In vitro efficacy, resistance selection, and structural modeling studies implicate the malarial parasite apicoplast as the target of azithromycin. J Biol Chem 282: 2494-2504.
64. Sommer DD, Delcher AL, Salzberg SL, Pop M. 2007. Minimus: A fast, lightweight genome assembler. BMC Bioinformatics 8: 64. doi: 10.1186/1471-2105-8-64.
65. Su X, Hayton K, Wellems TE. 2007. Genetic linkage and association analyses for trait mapping in Plasmodium falciparum. Nat Rev Genet 8: 497-506. (Pubitemid 46955213)
66. Tan TM, Nelson JS, Ng HC, Ting RC, Kara UA. 1997. Direct PCR amplification and sequence analysis of extrachromosomal Plasmodium DNA from dried blood spots. Acta Trop 68: 105-114.
67. Tan JC, Patel JJ, Tan A, Blain JC, Albert TJ, Lobo NF, Ferdig MT. 2009. Optimizing comparative genomic hybridization probes for genotyping and SNP detection in Plasmodium falciparum. Genomics 93: 543-550.
68. Trager W, Jenson JB. 1978. Cultivation of malarial parasites. Nature 273: 621-622.
69. Trott, O, Olson, AJ. 2009. AutoDock Vina: Improving the speed and accuracy of docking with a newscoring function, efficient optimization, and multithreading. J Comput Chem 31: 455-461.
70. Tu D, Blaha G, Moore PB, Steitz TA. 2005. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121: 257-270. (Pubitemid 40546393)
71. Uhlemann AC, Cameron A, Eckstein-Ludwig U, Fischbarg J, Iserovich P, Zuniga FA, East M, Lee A, Brady L, Haynes RK, et al. 2005. A single amino acid residue can determine the sensitivity of SERCAs to artemisinins. Nat Struct Mol Biol 12: 628-629. (Pubitemid 40980816)
72. Urdaneta L, Lal A, Barnabe C, Oury B, Goldman I, Ayala FJ, Tibayrenc M. 2001. Evidence for clonal propagation in natural isolates of Plasmodium falciparum from Venezuela. Proc Natl Acad Sci 98: 6725-6729.
73. Vester B, Douthwaite S. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob Agents Chemother 45: 1-12. (Pubitemid 32039086)
74. Volkman SK, Sabeti PC, DeCaprio D, Neafsey DE, Schaffner SF, Milner DA Jr, Daily JP, Sarr O, Ndiaye D, Ndir O, et al. 2007. A genome-wide map of diversity in Plasmodium falciparum. Nat Genet 39: 113-119.
75. Walliker D, Quakyi IA, Wellems TE, McCutchan TF, Szarfman A, London WT, Corcoran LM, Burkot TR, Carter R. 1987. Genetic analysis of the human malaria parasite Plasmodium falciparum. Science 236: 1661-1666.
76. Wang J, Wolf RM, Caldwell JW, Kollman PA, Case DA. 2004a. Development and testing of a general amber force field. J Comput Chem 25: 1157-1174.
77. Wang P, Nirmalan N, Wang Q, Sims PF, Hyde JE. 2004b. Genetic and metabolic analysis of folate salvage in the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 135: 77-87. (Pubitemid 38470077)
78. Wellems TE, Panton LJ, Gluzman IY, do Rosario VE, Gwadz RW, Walker-Jonah A, Krogstad DJ. 1990. Chloroquine resistance not linked to mdr-like genes in a Plasmodium falciparum cross. Nature 345: 253-255.
79. Winzeler EA. 2008. Malaria research in the post-genomic era. Nature 455: 751-756.
80. Winzeler EA, Richards DR, Conway AR, Goldstein AL, Kalman S, McCullough MJ, McCusker JH, Stevens DA, Wodicka L, Lockhart DJ, et al. 1998. Direct allelic variation scanning of the yeast genome. Science 281: 1194-1197. (Pubitemid 28406295)
81. Wongsrichanalai C, Barcus MJ, Muth S, Sutamihardja A, Wernsdorfer WH. 2007. A review of malaria diagnostic tools: Microscopy and rapid diagnostic test (RDT). Am J Trop Med Hyg 77 (Suppl): 119-127.
82. Wootton JC, Feng X, Ferdig MT, Cooper RA, Mu J, Baruch DI, Magill AJ, Su XZ. 2002. Genetic diversity and chloroquine selective sweeps in Plasmodium falciparum. Nature 418: 320-323. (Pubitemid 34790681)
83. Wu T, Nagle A, Sakata T, Henson K, Borboa R, Chen Z, Kuhen K, Plouffe D, Winzeler E, Adrian F, et al. 2009. Cell-based optimization of novel benzamides as potential antimalarial leads. Bioorg Med Chem Lett 19: 6970-6974.